Search
for

    GlossaryImatinib (Gleevec)

    targets specific enzymes to treat certain cancers like CML

    Imatinib, also known as Gleevec, is a targeted cancer therapy drug used primarily to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by inhibiting specific tyrosine kinases, which are enzymes that promote the growth of cancer cells, thereby slowing or stopping the progression of the disease.

    Related Terms

    Sort by

    Research

    29 / 29 results